Resultados: 63

Sacubitril-Valsartan lowers atrial fibrillation recurrence and left atrial volume post-catheter ablation: systematic review and meta-analysis

Am. j. cardiovasc. drugs; 25 (2), 2025
INTRODUCTION: In patients with atrial fibrillation (AF) who have undergone catheter ablation, the comparative effectiveness of sacubitril-valsartan (SV) versus ACE inhibitors (ACEi) or angiotensin-receptor blockers (ARB) in preventing AF recurrence remains unclear. The purpose of the present systematic r...

Combined left atrial appendage occlusion and catheter ablation for atrial fibrillation versus isolated left atrial appendage occlusion: A systematic review and meta-analysis

Int. j. cardiol; 421 (), 2025
BACKGROUND: Data on the effects of combined left atrial appendage occlusion (LAAO) and catheter ablation (CA) for atrial fibrillation (AF) remain limited. We aimed to perform a systematic review and meta-analysis comparing LAAO and CA versus isolated LAAO. METHODS: We systematically searched PubMed, Emba...

Catheter ablation approach and outcome in HIV+ patients with atrial fibrillation: a systematic review and meta-analysis

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Catheter ablation has emerged as an effective treatment option for atrial fibrillation (AF) in the general population. However, limited data exist on the outcomes of catheter ablation in patients infected with the Human Immunodeficiency Virus (HIV+) with concomitant AF. OBJECTIVES: This syste...

Hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: an updated systematic review and meta-analysis

Circulation; 150 (Suppl. 1), 2024
BACKGROUND: Some studies suggest a potential benefit of hybrid ablation for patients with persistent and long-standing persistent atrial fibrillation (AF), but its efficacy and safety remain debated. OBJECTIVE: We conducted a systematic review and meta-analysis to compare the efficacy and safety of hybri...

Clinical and genetic profiles of patients with hereditary and wild type transthyretin amyloidosis: the transthyretin cardiac amyloidosis registry in the state of Sao Paulo, Brazil REACT-SP

Eur. heart j; 45 (Suppl. 1), 2024
INTRODUCTION: Transthyretin amyloidosis (ATTR) is a multisystem disease caused by the deposition of fibrillar protein in organs and tissues. ATTR genotypes and phenotypes are highly heterogeneous. PURPOSE: We designed the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo (REACT-SP), a...

Comparative effectiveness of pulsed field ablation and cryoballoon ablation for atrial fibrillation: a systematic review and meta-analysis

Eur. heart j; 45 (Suppl. 1), 2024
BACKGROUND: Cryoballoon ablation (CBA) is a well-established technique for treating atrial fibrillation (AF), with a low complication rate related to cryoenergy-induced lesions. Pulsed Field Ablation (PFA) has emerged as a non-thermal alternative, with promising potential to further reduce complications....

Rivaroxaban Versus Warfarina ou Apixaban em pacientes diabéticos com fibrilação atrial não valvular: uma revisão sistemática e meta-análise
Rivaroxaban Versus Warfarin or Apixaban in diabetic patients with non-valvular atrial fibrillation: a systematic review and meta-analysis

Int. j. cardiovasc. sci. (Impr.); 37 (suppl.9), 2024
INTRODUÇÃO: Pacientes com fibrilação atrial não valvular (FANV) e diabetes mellitus (DM) têm até 70% mais risco de AVC do que pacientes com FANV e sem diabetes. Além disso, estudos ainda discutem se rivaroxaban e apixaban são alternativas ao tratamento tradicional com warfarina em pacientes com ...

Predictors of conduction system disturbances resulting in a new permanent pacemaker implantation within the Landmark Trial

J. Am. Coll. Cardiol; 84 (18 Suppl. B), 2024
BACKGROUND The need for permanent pacemaker implantation (PPMI) after transcatheter aortic valve implantation (TAVR) is a serious complication that adds additional risk for the patient. It also lengthens the hospitalization and increases costs. Unknown is the PPMI rate of the new balloon expandable Myval...

Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Herz; (), 2024
BACKGROUND: Patients who have undergone catheter ablation for atrial fibrillation (AF) may experience recurrence of this condition. The efficacy of sacubitril-valsartan (S/V) in preventing AF recurrence compared with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (AR...

Comparando a segurança da oclusão do apêndice atrial esquerdo, ablação por cateter e procedimentos combinados para a abordagem da fibrilação atrial: uma metanálise em rede
Comparing the safety of left atrial appendage occlusion, catheter ablation, and combined procedures for the management of atrial fibrillation: a network meta-analysis

Arq. bras. cardiol; 121 (9 supl.1), 2024
INTRODUÇÃO: O fechamento percutâneo transcateter do apêndice atrial esquerdo surgiu recentemente como uma alternativa segura e eficaz à terapia anticoagulante de longo prazo na prevenção de AVC e na redução dos riscos de sangramento em pacientes com FA não valvular. No entanto, o papel da combi...